Murine, chimeric, humanized or human anti-IL-6 antibodies
The present invention concerns compositions and methods of use of bispecific antibodies comprising at least one anti-TNF-α antibody or antigen-binding fragment thereof and at least one anti-IL-6 antibody or antigen-binding fragment thereof. Preferably, the bispecific antibody is in the form of a DNL® complex. The anti-TNF-α or anti-IL-6 antibodies may comprise specific CDR sequences disclosed herein. The compositions and methods are of use to treat autoimmune disease, immune system dysfunction or inflammatory disease, as disclosed herein.
IBC Pharmaceuticals, Inc.
C C C C A A A A C C C C C A C C C A C C A
C07K C07K C07K C07K A61K A61K A61K A61K C07K C07K C07K C07K C07K A61K C07K C07K C07K A61K C07K C07K A61K
additional additional additional inventional additional inventional inventional additional additional additional additional inventional additional inventional additional inventional additional inventional inventional additional inventional
David M. Chien-Hsing Rongxiu
Goldenberg Chang Li